Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
19 studies found for:    " December 10, 2008":" January 09, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 10, 2008":" January 09, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Pilot Study of a Raltegravir Based NRTI Sparing Regimen
Conditions: Acquired Immune Deficiency Syndrome;   AIDS;   Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Other: Standard treatment regimen
2 Completed Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1
Conditions: HIV-1;   HIV Infections
Intervention: Drug: Raltegravir
3 Completed Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia
Conditions: HIV;   Contraception;   HIV Infections
Interventions: Drug: Depo Provera;   Device: Copper T Intrauterine contraception device
4 Completed Plasma Citrulline Concentration in Tropical Enteropathy
Conditions: Malabsorption Syndromes;   Granulomatous Enteritis;   Enteritis;   HIV Enteropathy;   Ileal Diseases
Intervention:
5 Completed
Has Results
Lopinavir/Ritonavir (Kaletra) PK in Children
Conditions: HIV/AIDS Treatment;   HIV Infections
Intervention: Drug: lopinavir/ritonavir (Kaletra®) tablets
6 Completed Safety of the HIV Vaccine 732461 in HIV Infected Subjects Aged 18 to 55 Years Old
Condition: HIV (Human Immunodeficiency Virus)-Infected Adults
Interventions: Biological: HIV Vaccine 732461;   Biological: Placebo vaccine
7 Completed Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Maraviroc;   Drug: Tenofovir/Emtricitabine
8 Completed Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults
Condition: HIV Infections
Interventions: Biological: DNA Vaccine;   Biological: Placebo;   Biological: rMVA vaccine
9 Terminated Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?
Conditions: HIV Infections;   Helminthiasis
Intervention: Drug: Praziquantel, Ivermectin, Albendazole
10 Completed Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy
Conditions: Pregnancy;   Malaria;   HIV Infections
Interventions: Drug: Sulphadoxine-pyrimethamine;   Drug: Mefloquine (full dose);   Drug: Mefloquine (split dose);   Drug: placebo;   Drug: mefloquine
11 Unknown  Examination of B Cell Responses in Human Blood
Condition: HIV Infections
Intervention:
12 Completed
Has Results
Comparative Study of Three NNRTI-Sparing HAART Regimens
Condition: HIV Infection
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Atazanavir
13 Completed Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
Conditions: HIV Infection;   Fungal Infection
Interventions: Drug: Posaconazole;   Drug: Fosamprenavir;   Drug: Ritonavir
14 Completed
Has Results
Chloroquine for Reducing Immune Activation in HIV- Infected Individuals
Condition: HIV Infections
Interventions: Drug: Chloroquine;   Drug: Placebo
15 Completed
Has Results
Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients
Condition: HIV Infections
Interventions: Drug: Nevirapine XR;   Drug: Nevirapine IR
16 Completed Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults
Condition: HIV Infections
Intervention: Drug: Structured treatment interruption
17 Enrolling by invitation Safety And Efficacy Of Rifabutin In HIV Patients
Conditions: Non-tuberculous Mycobacterial Diseases (Including MAC Disease);   Tuberculosis;   Inhibition of Disseminated Mycobacterium Avium Complex (MAC) Disease Associated With HIV Infections
Intervention: Drug: rifabutin
18 Completed TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation
Conditions: Pharmacokinetics;   Bioavailability;   HIV-1
Intervention: Drug: TMC278
19 Completed Beta-2 Microglobulin and Serum Cytokines x HAART
Condition: HIV Patients
Intervention:

Indicates status has not been verified in more than two years